Muscarinic Cholinergic Receptor Agonist and Peripheral Antagonist for Schizophrenia

News
1
4 Likes
2

both positive and negative symptoms reduction right …
cool…
@twinklestars

1 Like
3

Isn’t this old news? I remember the phase ii trial is out ages ago. Anyway when they say no weight gain, is it that no weight gain from antipsychotic treated weight or pre-antipsychotic treated weight?

1 Like
4

Yes, this abstract doesn’t say by how much, but they measured negative symptoms (Marder subscore) and it says the active group had significantly better responses on the secondary measures (Negatives being one of the secondary measures.)

1 Like
5

This is from feb 2021, but maybe it’s another study to peer review the original findings?

image
image640×1136 93.7 KB

1 Like
6

@twinklestars how a schizophrenia patient diagnosed as disabled …?
what is the test and examination called … ???
I havent diagnosed as disable but F:20 already …

7

I think this depends on the standards where you are. Your doctor could probably tell you.

1 Like